GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangxi Fushine Pharmaceutical Co Ltd (SZSE:300497) » Definitions » 14-Day RSI

Jiangxi Fushine Pharmaceutical Co (SZSE:300497) 14-Day RSI : 62.35 (As of Sep. 27, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Jiangxi Fushine Pharmaceutical Co 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-09-27), Jiangxi Fushine Pharmaceutical Co's 14-Day RSI is 62.35.

The industry rank for Jiangxi Fushine Pharmaceutical Co's 14-Day RSI or its related term are showing as below:

SZSE:300497's 14-Day RSI is ranked worse than
88.75% of 1547 companies
in the Biotechnology industry
Industry Median: 46.1 vs SZSE:300497: 62.35

Competitive Comparison of Jiangxi Fushine Pharmaceutical Co's 14-Day RSI

For the Biotechnology subindustry, Jiangxi Fushine Pharmaceutical Co's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangxi Fushine Pharmaceutical Co's 14-Day RSI Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jiangxi Fushine Pharmaceutical Co's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Jiangxi Fushine Pharmaceutical Co's 14-Day RSI falls into.



Jiangxi Fushine Pharmaceutical Co  (SZSE:300497) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jiangxi Fushine Pharmaceutical Co  (SZSE:300497) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Jiangxi Fushine Pharmaceutical Co 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Jiangxi Fushine Pharmaceutical Co's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangxi Fushine Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No.2 YULI Industrial Zone, Changjiang district, Jiangxi Province, Jingdezhen, CHN, 333000
Jiangxi Fushine Pharmaceutical Co Ltd is engaged in research and development, manufactures and sells APIs and pharmaceutical intermediates. It offers penicillin, carbapenem, and other products.
Executives
Liu Ying Executives
Peng Yun Secretary Dong
Zhang Xiang Ming Executives
Wei Hai Peng Executives
Bao Jian Hua Directors, executives
Li Hui Yue Director
Dai Zhen Liang Executives
Yang Guang Executives
Chen Ying Hui Executives
Ke Dan Director
Xu Chun Xia Directors, executives
Yu Wen Jun Director
Cheng Rong Wu Directors, executives
Liu Zhi Min Executives
Tang De Ping Executives

Jiangxi Fushine Pharmaceutical Co Headlines

No Headlines